{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:22:18Z","timestamp":1793758938712,"version":"4.6.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the effect of radioactive iodine therapy under thyroid hormone withdrawal in differentiated thyroid cancer patients on health-related quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients who were diagnosed with differentiated thyroid cancer after thyroidectomy were involved in this study. All of them were managed with thyroid hormone withdrawal. Health-related quality of life was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and its thyroid cancer module at three different time points. Changes in health-related quality of life were evaluated by Wilcoxon and Kruskal\u2013Wallis tests. Univariable logistic regression analysis was used to determine social-demographic and clinical factors associated with worse health-related quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 99 differentiated thyroid cancer patients were involved in this study. Changes in health-related quality of life at different time points showed that 1\u00a0month post-radioactive iodine treatment, an improvement in nausea and vomiting, insomnia and appetite loss was observed. Impairments of global health, role, cognitive and social function and problems of discomfort in the head and neck, voice concerns, dry mouth, fatigue, pain, dyspnea, thyroid fatigue, fear, tingling or numbness, joint pain and shoulder function increased after radioactive iodine treatment. Univariable logistic regression analysis demonstrated potential factors associated with worse health-related quality of life. Thyroid stimulating hormone and parathyroid hormone levels were more sensible to changes in functional domain. Patients aged \u226555-year-old, with annual income under \u00a550\u2009000, low parathyroid hormone and pT4 tumour stage experienced higher changes in symptom scales after radioactive iodine treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>After radioactive iodine treatment, differentiated thyroid cancer patients experienced negative health-related quality of life, and most of these impairments might not recover in the short term. Thyroid stimulating hormone and parathyroid hormone levels, annual income and pT tumours stage were independent risk factors for decreased health-related quality of life.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyac113","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T13:43:37Z","timestamp":1658151817000},"source":"Crossref","is-referenced-by-count":6,"title":["Effect of radioiodine therapy under thyroid hormone withdrawal on health-related quality of life in patients with differentiated thyroid cancer"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-6795","authenticated-orcid":false,"given":"Hui","family":"Ming","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine , Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2022071813423268200_ref1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"2022071813423268200_ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2022071813423268200_ref3","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol"},{"key":"2022071813423268200_ref4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21147\/j.issn.1000-9604.2019.01.09","article-title":"Incidence and mortality of thyroid cancer in China, 2008-2012","volume":"31","author":"Du","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"2022071813423268200_ref5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-16-0530","article-title":"The EORTC module for quality of life in patients with thyroid cancer: phase III","volume":"24","author":"Singer","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2022071813423268200_ref6","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1007\/s00520-019-05225-x","article-title":"Health-related quality of life of thyroid cancer patients undergoing radioiodine therapy: a cohort real-world study in a reference public cancer hospital in Brazil","volume":"28","author":"Ramim","year":"2020","journal-title":"Support Care Cancer"},{"key":"2022071813423268200_ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-13-165","article-title":"Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy","volume":"13","author":"Hong","year":"2013","journal-title":"BMC Cancer"},{"key":"2022071813423268200_ref8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00268-019-05249-8","article-title":"Cardiovascular incidence in 6900 patients with differentiated thyroid cancer: a Swedish Nationwide study","volume":"44","author":"Zoltek","year":"2020","journal-title":"World J Surg"},{"key":"2022071813423268200_ref9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1089\/thy.2020.0038","article-title":"Patient-reported quality-of-life outcome measures in the thyroid cancer population","volume":"30","author":"Roth","year":"2020","journal-title":"Thyroid"},{"key":"2022071813423268200_ref10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S0022215120002571","article-title":"Does the radioactive iodine dose affect smell, taste sensation and nose function?","volume":"135","author":"Tutar","year":"2021","journal-title":"J Laryngol Otol"},{"key":"2022071813423268200_ref11","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1002\/hed.26359","article-title":"Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: long-term study","volume":"42","author":"Le Roux","year":"2020","journal-title":"Head Neck"},{"key":"2022071813423268200_ref12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/eos.12689","article-title":"Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation","volume":"128","author":"Krcalova","year":"2020","journal-title":"Eur J Oral Sci"},{"key":"2022071813423268200_ref13","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/lary.28342","article-title":"Does salivary function decrease in proportion to radioiodine dose?","volume":"130","author":"Kim","year":"2020","journal-title":"Laryngoscope"},{"key":"2022071813423268200_ref14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11764-020-00897-5","article-title":"Looking under the hood of ``the Cadillac of cancers:'' radioactive iodine-related craniofacial side effects among patients with thyroid cancer","volume":"14","author":"Diamond-Rossi","year":"2020","journal-title":"J Cancer Surviv"},{"key":"2022071813423268200_ref15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4143\/crt.2017.012","article-title":"Development and evaluation of a Korean version of a thyroid-specific quality-of-life questionnaire scale in thyroid cancer patients","volume":"50","author":"Ryu","year":"2018","journal-title":"Cancer Res Treat"},{"key":"2022071813423268200_ref16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clinimag.2014.12.018","article-title":"Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose","volume":"39","author":"Lee","year":"2015","journal-title":"Clin Imaging"},{"key":"2022071813423268200_ref17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00003072-200211000-00003","article-title":"Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment","volume":"27","author":"Caglar","year":"2002","journal-title":"Clin Nucl Med"},{"key":"2022071813423268200_ref18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/MNM.0000000000000325","article-title":"Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up","volume":"36","author":"Wu","year":"2015","journal-title":"Nucl Med Commun"},{"key":"2022071813423268200_ref19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fendo.2015.00100","article-title":"Salivary function after radioiodine therapy: poor correlation between symptoms and salivary scintigraphy","volume":"6","author":"Jonklaas","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022071813423268200_ref20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s42000-020-00186-x","article-title":"Quality of life of patients more than 1 year after surgery for thyroid cancer","volume":"19","author":"Buttner","year":"2020","journal-title":"Hormones (Athens)"},{"key":"2022071813423268200_ref21","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/hed.25325","article-title":"Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: results from the PROFILES registry","volume":"40","author":"Mols","year":"2018","journal-title":"Head Neck"},{"key":"2022071813423268200_ref22","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.2147\/CMAR.S235323","article-title":"Risk factors of deterioration in quality of life scores in thyroid cancer patients after thyroidectomy","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"key":"2022071813423268200_ref23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ando.2018.01.003","article-title":"Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid","volume":"80","author":"Haraj","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"2022071813423268200_ref24","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa597","article-title":"Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer","volume":"105","author":"B\u00fcttner","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2022071813423268200_ref25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12020-020-02238-z","article-title":"Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian population","volume":"69","author":"Tang","year":"2020","journal-title":"Endocrine"},{"key":"2022071813423268200_ref26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.eprac.2021.01.005","article-title":"Patient perspectives on the extent of surgery and radioactive iodine treatment for low-risk differentiated thyroid cancer","volume":"27","author":"Lubitz","year":"2021","journal-title":"Endocr Pract"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyac113\/44886776\/hyac113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyac113\/44886776\/hyac113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T13:44:01Z","timestamp":1658151841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article\/doi\/10.1093\/jjco\/hyac113\/6644513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyac113","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"hyac113"}}